A News Agency

US President Donald Trump signed an executive order aimed at strengthening research, prevention, diagnosis, treatment and care to improve health outcomes for women and girls throughout all stages of life.

According to a fact sheet released by the White House on October 19, the executive order, championed by First Lady Melania Trump, seeks to ensure that federal efforts on women's health are carried out comprehensively and in a coordinated manner.

The order provides for the establishment of a White House Women's Health Task Force. The task force is expected to consider women's changing health needs from infancy, childhood and adolescence through pregnancy, middle age, menopause and older age, while supporting policy and regulatory efforts to develop prevention, diagnosis, treatment and care services appropriate to each stage of life.

The order also directs the US Secretary of Health and Human Services and the Director of the National Institutes of Health to establish a Division of Women's Health within the institutes. The division is intended to strengthen research coordination, identify gaps in scientific knowledge and accelerate the translation of research findings into clinical practice.

The fact sheet states that initiatives introduced by the previous administration will be rescinded, while the new approach will prioritize not only research but also translating scientific findings into better clinical outcomes for women and girls.

The White House states that many diseases and conditions that disproportionately affect women or are specific to women have not received sufficient research, clinical attention or treatment despite advances in biomedical science.

Areas identified as requiring further research include cardiovascular diseases, cancer, stroke, Alzheimer's disease, autoimmune and inflammatory diseases, osteoporosis, mental health, chronic pain, endometriosis, uterine fibroids, polycystic metabolic ovary syndrome (PMOS), infertility, maternal health, menopause, neurological diseases and aging.

The fact sheet emphasizes the need to strengthen federal coordination, scientific investment and the translation of research findings into clinical practice and community-based services to achieve better outcomes in women's health.

The White House presents the new women's health initiative as part of the Trump administration's goal of making healthcare more accessible and affordable.

The fact sheet notes the publication of new Dietary Guidelines for Americans, including sections for pregnant and breastfeeding women. It also states that, under the Working Families Tax Cuts Act, access to health savings accounts through Obamacare has been expanded to up to 10 million people and that $50 billion has been invested to improve rural healthcare services.

According to the statement, 46 states have made investments in maternal health, including telehealth, remote patient monitoring, maternity care workforce development and postpartum care.

The White House also reported that the US Food and Drug Administration initiated the process of removing broad "black box" warnings from hormone replacement therapy products for menopause in November 2025.

The fact sheet states that 26 agreements reached with pharmaceutical manufacturers cover approximately 90 percent of the branded drug market, and that the Council of Economic Advisers estimates these agreements will generate $600 billion in prescription drug savings over the next 10 years.

It was claimed that patients can obtain discounts on certain medications through TrumpRx.gov, launched in February 2026, and that more than $700 million in drug spending has been saved since the platform's launch. The statement also indicated that certain medications used in infertility treatment offer average savings of more than $2,000 per patient per treatment cycle.

The Moms.gov platform, launched in May 2026, was also described as an initiative intended to provide information and support to families during pregnancy and early parenthood.